ARGQ — Argentum 47 Share Price
- $1.65m
- $2.31m
- $0.11m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 18.06 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -397.21% |
Financial Summary
Year End 31st Dec | Unit | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 3.31 | 1.51 | 0.22 | 0.1 | 0.11 | n/a | n/a | -26.29% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | -83.25 | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Argentum 47, Inc. provides specialized training and educational services to the biopharmaceutical and pharmaceutical industries. The Company's comprehensive programs are focused on advancing regulatory compliance, aseptic processes, and manufacturing proficiency, ensuring alignment with the industry standards for operational excellence and quality assurance.
Directors
- Last Annual
- December 31st, 2019
- Last Interim
- September 30th, 2020
- Incorporated
- October 1st, 2010
- Public Since
- September 19th, 2012
- No. of Employees
- 5
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 210,291,279

- Address
- X3 Jumeirah Bay Tower, Office 3305,, DUBAI, 340100
- Web
- https://www.argq.io/
- Phone
- +971 42767576
- Auditors
- Salberg & Company, P.A.
Upcoming Events for ARGQ
Similar to ARGQ
1PM Industries
Pink Sheets on Nasdaq
3Dshopping.Com
Pink Sheets on Nasdaq
3 Sixty Risk Solutions
Pink Sheets on Nasdaq
Adecco AG
Pink Sheets on Nasdaq
Adm Endeavors
Pink Sheets on Nasdaq
FAQ
As of Today at 19:20 UTC, shares in Argentum 47 are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in Argentum 47 last closed at $0.01 and the price had moved by -71.33% over the past 365 days. In terms of relative price strength the Argentum 47 share price has underperformed the S&P500 Index by -72.91% over the past year.
There is no consensus recommendation for this security.
Find out moreArgentum 47 does not currently pay a dividend.
Argentum 47 does not currently pay a dividend.
Argentum 47 does not currently pay a dividend.
To buy shares in Argentum 47 you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in Argentum 47 had a market capitalisation of $1.65m.
Here are the trading details for Argentum 47:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ARGQ
Based on an overall assessment of its quality, value and momentum Argentum 47 is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Argentum 47. Over the past six months, its share price has outperformed the S&P500 Index by +20.98%.
As of the last closing price of $0.01, shares in Argentum 47 were trading -81.68% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Argentum 47 PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Argentum 47's management team is headed by:
- Nicholas Tuke - PRE
- Enzo Taddei - CFO
- Peter Smith - DRC